To evaluate the effects (up to one year of age) of indomethacin on the clinical course of
patent ductus arteriosus (PDA) in premature infants (24 hours old or less) and to assess the
relative merits of indomethacin and surgery in infants with persistent respiratory distress
who were not treated early with indomethacin. Two concurrent trials were performed.